GPC1 and pancreatic neoplasm: Recently, a milestone study has shown that glypican-1 (GPC1) positive exosomes were detectable in the serum of patients with pancreatic cancer with a high level of specificity and sensitivity, as compared to both healthy subjects and patients with a benign pancreatic disease [69].